- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Elastolysis in COPD: a Target for Therapy ; volume:202 ; number:3 ; day:27 ; month:4 ; year:2024 ; pages:233-234 ; date:6.2024
Lung ; 202, Heft 3 (27.4.2024), 233-234, 6.2024
- Urheber
-
Turino, Gerard M.
Cantor, Jerome O.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00408-024-00693-3
- URN
-
urn:nbn:de:101:1-2408082105511.806462217619
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Turino, Gerard M.
- Cantor, Jerome O.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Interferon therapy for preventing COPD exacerbations
Proteases as targets for therapy
New drugs and targets for asthma and COPD : 46 tables
Progress in the mechanism and targeted drug therapy for COPD
Target selection for CAR-T therapy
Evolving targets for lipid‐modifying therapy
TargetCOPD: a pragmatic randomised controlled trial of targeted case finding for COPD versusroutine practice in primary care: protocol
Inhalation Therapy for Stable COPD: 20 Years of GOLD Reports
N-α-PGP and PGP, potential biomarkers and therapeutic targets for COPD
Survivin: a unique target for tumor therapy
PPARG as therapeutic target for antifibrotic therapy
Squalene monooxygenase – a target for hypercholesterolemic therapy
Interferon therapy for preventing COPD exacerbations
Proteases as targets for therapy
New drugs and targets for asthma and COPD : 46 tables
Progress in the mechanism and targeted drug therapy for COPD
Target selection for CAR-T therapy
Evolving targets for lipid‐modifying therapy
TargetCOPD: a pragmatic randomised controlled trial of targeted case finding for COPD versusroutine practice in primary care: protocol
Inhalation Therapy for Stable COPD: 20 Years of GOLD Reports
N-α-PGP and PGP, potential biomarkers and therapeutic targets for COPD
Survivin: a unique target for tumor therapy
PPARG as therapeutic target for antifibrotic therapy
Squalene monooxygenase – a target for hypercholesterolemic therapy
Interferon therapy for preventing COPD exacerbations
Proteases as targets for therapy
New drugs and targets for asthma and COPD : 46 tables
Progress in the mechanism and targeted drug therapy for COPD
Target selection for CAR-T therapy
Evolving targets for lipid‐modifying therapy
TargetCOPD: a pragmatic randomised controlled trial of targeted case finding for COPD versusroutine practice in primary care: protocol
Inhalation Therapy for Stable COPD: 20 Years of GOLD Reports
N-α-PGP and PGP, potential biomarkers and therapeutic targets for COPD
Survivin: a unique target for tumor therapy
PPARG as therapeutic target for antifibrotic therapy